ORANGE COUNTY, Calif. (September 4, 2008) – Agencourt Bioscience Corporation, a Beckman Coulter company, announced today that its Genomic Services provided sequencing for whole-genome scanning in two Johns Hopkins studies to be published this week in Science Express. In both studies, Agencourt employed Sanger sequencing technology for high-throughput discovery of gene mutations associated with specific cancers. The two new studies are part of an ongoing collaboration between Agencourt and Johns Hopkins Kimmel Cancer Center, which announced the discovery of 200 genes linked to breast and colon cancers in 2007. James Hartigan and Douglas Smith of Agencourt were among the authors of the new papers and worked closely with the study leader, Dr. Victor Velculescu.
